Showing 1 - 5 results of 5 for search 'Erpenbeck, V', query time: 0.02s
Refine Results
-
1
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s) by Sandham, D, Chen, W, Hardman, C, Luo, J, Xue, L, Ogg, G, Erpenbeck, V
Published 2019Conference item -
2
-
3
-
4
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s) by Chen, W, Hardman, C, Batty, P, Luo, J, Wu, Y, Xue, L, Ogg, G, Sandham, D, Erpenbeck, V
Published 2018Conference item -
5
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function by Hardman, C, Chen, W, Luo, J, Batty, P, Chen, Y, Nahler, J, Wu, Y, Pavord, I, Erpenbeck, V, Sandham, D, Xue, L, Ogg, G
Published 2019Journal article